Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
Department of Neurology, Donders Institute for Brain, Behaviour and Cognition, Radboud University Medical Centre, Nijmegen, The Netherlands.
Eur J Neurol. 2021 Dec;28(12):3883-3920. doi: 10.1111/ene.15068. Epub 2021 Sep 13.
The optimal management of post-stroke cognitive impairment (PSCI) remains controversial. These joint European Stroke Organisation (ESO) and European Academy of Neurology (EAN) guidelines provide evidence-based recommendations to assist clinicians in decision making regarding prevention, diagnosis, treatment and prognosis.
Guidelines were developed according to the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) methodology. The working group identified relevant clinical questions, performed systematic reviews, assessed the quality of the available evidence, and made specific recommendations. Expert consensus statements were provided where insufficient evidence was available to provide recommendations.
There was limited randomized controlled trial (RCT) evidence regarding single or multicomponent interventions to prevent post-stroke cognitive decline. Lifestyle interventions and treating vascular risk factors have many health benefits, but a cognitive effect is not proven. We found no evidence regarding routine cognitive screening following stroke, but recognize the importance of targeted cognitive assessment. We describe the accuracy of various cognitive screening tests, but found no clearly superior approach to testing. There was insufficient evidence to make a recommendation for use of cholinesterase inhibitors, memantine nootropics or cognitive rehabilitation. There was limited evidence on the use of prediction tools for post-stroke cognition. The association between PSCI and acute structural brain imaging features was unclear, although the presence of substantial white matter hyperintensities of presumed vascular origin on brain magnetic resonance imaging may help predict cognitive outcomes.
These guidelines highlight fundamental areas where robust evidence is lacking. Further definitive RCTs are needed, and we suggest priority areas for future research.
脑卒中后认知障碍(PSCI)的最佳管理仍存在争议。这些由欧洲卒中组织(ESO)和欧洲神经病学会(EAN)联合制定的指南提供了循证建议,以帮助临床医生在预防、诊断、治疗和预后方面做出决策。
指南的制定遵循推荐分级、评估、制定与评价(GRADE)方法。工作组确定了相关的临床问题,进行了系统评价,评估了现有证据的质量,并提出了具体建议。在证据不足无法提供建议的情况下,提供了专家共识声明。
关于预防脑卒中后认知下降的单一或多种干预措施的随机对照试验(RCT)证据有限。生活方式干预和治疗血管危险因素有许多健康益处,但没有证明对认知有影响。我们没有发现脑卒中后常规认知筛查的证据,但认识到进行有针对性的认知评估的重要性。我们描述了各种认知筛查测试的准确性,但没有发现明显优于其他测试的方法。没有证据表明使用胆碱酯酶抑制剂、美金刚、认知康复。对于预测脑卒中后认知的工具的使用,证据有限。PSCI 与急性结构性脑成像特征之间的关系尚不清楚,尽管脑磁共振成像上存在大量推测为血管源性的脑白质高信号可能有助于预测认知结局。
这些指南突出了缺乏强有力证据的基本领域。需要进一步进行确定性 RCT,我们建议确定未来研究的优先领域。